The dual pathway inhibitor rigosertib is effective in direct-patient tumor xenografts of head and neck squamous cell carcinomas
收藏ChEBI2013-06-13 更新2026-07-21 收录
下载链接:
https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-47864
下载链接
链接失效反馈官方服务:
资源简介:
The dual pathway inhibitor rigosertib is effective in direct-patient tumor xenografts of head and neck squamous cell carcinomas
创建时间:
2013-06-13




